Antiangiogenic and chemopreventive activities of celecoxib in oral carcinoma cell

Laryngoscope

Volumn 112, Issue 5, 2002, Pages 839-843

  Wang, Zhi ^a   Fuentes, Cesar F ^a   Shapshay, Stanley M ^a  

^a TUFTS MEDICAL CENTER   (United States)

Author keywords

Angiogenesis; Celecoxib; Chemoprevention; Oral cancer

Indexed keywords

CELECOXIB;

ANGIOGENESIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER GRAFT; CANCER INHIBITION; CANCER PREVENTION; CONTROLLED STUDY; DRUG EFFICACY; HUMAN; HUMAN CELL; MOUSE; MOUTH CARCINOMA; NONHUMAN; NUDE MOUSE; PRIORITY JOURNAL; TUMOR VASCULARIZATION;

ADMINISTRATION, ORAL; ANGIOGENESIS INHIBITORS; ANIMALS; CARCINOMA, SQUAMOUS CELL; CELL DIVISION; CELL TRANSFORMATION, NEOPLASTIC; CYCLOOXYGENASE INHIBITORS; HUMANS; KB CELLS; MICE; MICE, NUDE; MOUTH NEOPLASMS; NEOPLASM TRANSPLANTATION; NEOVASCULARIZATION, PATHOLOGIC; PYRAZOLES; SULFONAMIDES;

EID: 0036254638     PISSN: 0023852X     EISSN: None     Source Type: Journal    
DOI: 10.1097/00005537-200205000-00012     Document Type: Article

References (19)

1. Cancer statistics
2. COX2 inhibitor
3. Cyclooxygenase-2 inhibitor in tumorigenesis, part I
4. Cyclooxygenase regulates angiogenesis induced by colon cancer cells
5. Chemopreventive activity of celecoxib, a specific cyclooxygenase-2 inhibitor, against colon carcinogenesis
6. A selective cyclooxygenase-2 inhibitor suppresses tumor growth in nude mouse xenografted with human head and neck squamous carcinoma cells
7. Antiangiogenic and antitumor activities of cyclooxygenase-2 inhibitors
8. Tumor growth inhibition and regression induced by photothermal vascular targeting and angiogenesis inhibitor retinoic acid
9. Effects of tamoxifen and interferon-B or the combination on tumor-induced angiogenesis
10. Retinoic acid and interferon a act synergistically as antiangiogenic and antitumor agents against human head and neck squamous
11. The cyclooxygenase-2 inhibitor celecoxib is a potent preventive and therapeutic agent in the min mouse model of a denomatous polyposis
12. Suppression of intestinal polyposis in Apc716 knockout mice by inhibition of cyclooxygenase 2 (COX2)
13. Pharmacokinetics, tissue distribution, metabolism and excretion of celecoxib in rats
14. Cyclooxygenase-2 inhibitor in tumorigenesis (part II)
15. A model of angiogenesis in the mouse cornea
16. Cyclooxygenase-2 expression is up-regulated in squamous cell carcinoma of the head and neck
17. Reduced risk of upper gastrointestinal ulcer complications with Celecoxib, a novel COX-2 inhibitor
18. The effect of celecoxib, a cyclooxygenase-2 inhibitor, in familial adenomatous polyposis
19. Update on clinical developments with celecoxib, a new specific COX-2 inhibitor: What can we expect?